title: Acute bacterial suppurative parotitis: microbiology and management.
abstract: The parotid gland is the salivary gland most commonly affected by inflammation. The most common pathogens associated with acute bacterial parotitis are Staphylococcus aureus and anaerobic bacteria. The predominant anaerobes include gram-negative bacilli (including pigmented Prevotella and Porphyromonas spp.), Fusobacterium spp., and Peptostreptococcus spp. Streptococcus spp. (including S. pneumoniae) and gram-negative bacilli (including Escherichia coli) have also been reported. Gram-negative organisms are often seen in hospitalized patients. Organisms less frequently found are Arachnia, Haemophilus influenzae, Klebsiella pneumoniae, Salmonella spp., Pseudomonas aeruginosa, Treponema pallidum, cat-scratch bacillus, and Eikenella corrodens. Mycobacterium tuberculosis and atypical mycobacteria are rare causes of parotitis. Therapy includes maintenance of hydration and administration of parenteral antimicrobial therapy. Once an abscess has formed surgical drainage is required. The choice of antimicrobial depends on the etiologic agent. Maintenance of good oral hygiene, adequate hydration, and early and proper therapy of bacterial infection of the oropharynx may reduce the occurrence of suppurative parotitis.
authors.affiliation: Georgetown University School of Medicine, Washington, DC, USA. ib6@goergetown.edu
authors.forename: Itzhak
authors.initials: I
authors.lastname: Brook
mesh_terms: D000038:Abscess / Q000188:drug therapy / Q000601:surgery; D000193:Actinomycetales Infections / Q000175:diagnosis / Q000188:drug therapy; D000208:Acute Disease; D001424:Bacterial Infections / Q000175:diagnosis* / Q000188:drug therapy; D016866:Bacteroidaceae Infections / Q000175:diagnosis / Q000188:drug therapy; D002372:Cat-Scratch Disease / Q000175:diagnosis / Q000188:drug therapy; D004322:Drainage; D016124:Eikenella corrodens / Q000302:isolation & purification; D005440:Fluid Therapy; D005674:Fusobacterium Infections / Q000175:diagnosis / Q000188:drug therapy; D016905:Gram-Negative Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy; D016908:Gram-Positive Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy; D006192:Haemophilus Infections / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007710:Klebsiella Infections / Q000175:diagnosis / Q000188:drug therapy; D009910:Oral Hygiene; D010309:Parotitis / Q000188:drug therapy / Q000382:microbiology*; D010462:Peptostreptococcus / Q000302:isolation & purification; D017861:Porphyromonas / Q000302:isolation & purification; D018720:Prevotella / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000175:diagnosis / Q000188:drug therapy; D012480:Salmonella Infections / Q000175:diagnosis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy; D013290:Streptococcal Infections / Q000175:diagnosis / Q000188:drug therapy; D013492:Suppuration; D014211:Treponemal Infections / Q000175:diagnosis / Q000188:drug therapy; D014393:Tuberculosis, Oral / Q000175:diagnosis / Q000188:drug therapy